AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. RARE
  4. [S-8] Ultragenyx Pharmaceutical Inc. Employee Benefit Plan Registration

[S-8] Ultragenyx Pharmaceutical Inc. Employee Benefit Plan Registration

Filing Impact
(No impact)
Filing Sentiment
(Neutral)
Form Type
S-8

Filing content is currently unavailable.

Source:

Stock RARE logo
Ultragenyx Pharm

NASDAQ:RARE

RARE Rankings

#1777 Ranked by Market Cap
N/A Ranked by Dividends

RARE Latest News

Aug 21, 2025
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Aug 18, 2025
Ultragenyx Initiates Rolling Submission of Biologics License Application (BLA) to U.S. FDA for DTX401 AAV Gene Therapy for the Treatment of Glycogen Storage Disease Type Ia (GSDIa)
Aug 5, 2025
Ultragenyx Reports Second Quarter 2025 Financial Results and Corporate Update
Jul 31, 2025
Ultragenyx Completes Enrollment of Phase 3 Aspire Study Evaluating GTX-102 for the Treatment of Angelman Syndrome
Jul 30, 2025
Ultragenyx to Host Conference Call for Second Quarter 2025 Financial Results and Corporate Update

RARE Latest SEC Filings

Aug 18, 2025
[8-K] Ultragenyx Pharmaceutical Inc. Reports Material Event
Aug 5, 2025
[8-K] Ultragenyx Pharmaceutical Inc. Reports Material Event
Jul 31, 2025
[8-K] Ultragenyx Pharmaceutical Inc. Reports Material Event
Jul 11, 2025
[8-K] Ultragenyx Pharmaceutical Inc. Reports Material Event
Jul 9, 2025
[8-K] Ultragenyx Pharmaceutical Inc. Reports Material Event

RARE Stock Data

2.81B
92.01M
3.14%
101.42%
7.93%
Biotechnology
Pharmaceutical Preparations
United States
NOVATO